Immunoregulation in normal pregnancy and pre-eclampsia: An overview

Reproductive BioMedicine Online

Volumn 13, Issue 5, 2006, Pages 680-686

  Sargent, Ian L ^a   Borzychowski, Angela M ^a   Redman, Chris W G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

HLA C; HLA G; Placental debris; Pre eclampsia; Th1 Th2

Indexed keywords

ANGIOGENIC FACTOR; CD56 ANTIGEN; FETAL ANTIGEN; GAMMA INTERFERON; HLA C ANTIGEN; HLA G ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 4; NATURAL KILLER CELL RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTERY; CELL FUNCTION; CELL INTERACTION; CELL INVASION; CLINICAL FEATURE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DECIDUA; ENDOTHELIUM; HUMAN; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFLAMMATION; LEUKOCYTE; NATURAL KILLER CELL; OXIDATIVE STRESS; PATHOGENESIS; PLACENTA; PLACENTA CIRCULATION; PREECLAMPSIA; PREGNANCY; REVIEW; SPIRAL ARTERY; SYNCYTIOTROPHOBLAST; SYSTEMIC CIRCULATION; TROPHOBLAST;

EID: 33751074998     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60659-1     Document Type: Article

References (39)

1. Borzychowski AM, Croy BA, Chan WL et al. 2005 Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells. European Journal of Immunology 35, 3054-3063.
2. Carter LL, Dutton RW 1995 Relative perforin- and Fas-mediated lysis in T1 and T2 CD8 effector populations. Journal of Immunology 155, 1028-1031.
3. Chan WL, Yen CH, Wong KK et al. 2001 Human IL-18 receptor and ST2L are stable and selective markers for the respective type 1 and type 2 circulating lymphocytes. Journal of Immunology 167, 1238-1244.
4. Dekker GA, Robillard PY 2005 Preeclampsia: a couple's disease with maternal and fetal manifestations. Current Pharmaceutical Design 11, 699-710.
5. Demirtas O, Gelal F, Vidinli BD et al. 2005 Cranial MR imaging with clinical correlation in preeclampsia and eclampsia. Diagnostic and Interventional Radiology 11, 189-194.
6. Emmer PM, Steegers EA, Kerstens HM et al. 2002 Altered phenotype of HLA-G expressing trophoblast and decidual natural killer cells in pathological pregnancies. Human Reproduction 17, 1072-1080.
7. Fuzzi B, Rizzo R, Criscuoli L et al. 2002 HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. European Journal of Immunology 32, 311-315.
8. + regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. Journal of Experimental Medicine 202, 1075-1085.
9. Godfrey DI, Kronenberg M 2004 Going both ways: immune regulation via CD1d-dependent NKT cells. Journal of Clinical Investigation 114, 1379-1388.
10. Goldman-Wohl DS, Ariel I, Greenfield C et al. 2000 Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Molecular Human Reproduction 6, 88-95.
11. Gupta AK, Rusterholz C, Huppertz B et al. 2005 A comparative study of the effect of three different syncytiotrophoblast microparticles preparations on endothelial cells. Placenta 26, 59-66.
12. Haller H, Hempel A, Homuth V et al. 1998 Endothelial-cell permeability and protein kinase C in pre-eclampsia. Lancet 351. 945-949.
13. Hiby SE, Walker JJ, O'Shaughnessy KM et al. 2004 Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. Journal of Experimental Medicine 200, 957-965.
14. Hviid TV 2006 HLA-G in human reproduction: aspects of genetics, function and pregnancy complications. Human Reproduction Update 12, 209-232.
15. Ishitani A, Sageshima N, Hatake K 2006 The involvement of HLA-E and -F in pregnancy. Journal of Reproductive Immunology 69, 101-113.
16. Lafayette RA, Druzin M, Sibley R et al. 1998 Nature of glomerular dysfunction in pre-eclampsia. Kidney International 54, 1240-1249.
17. Moffett-King A 2002 Natural killer cells and pregnancy. Nature Reviews Immunology 2, 656-663.
18. Paeschke S, Chen F, Horn N et al. 2005 Pre-eclampsia is not associated with changes in the levels of regulatory T cells in peripheral blood. American Journal Reproductive Immunology 54, 384-389.
19. Perritt D, Robertson S, Gri G et al. 1998 Differentiation of human NK cells into NK1 and NK2 subsets. Journal of Immunology 161, 5821-5824.
20. Piccinni MP, Scaletti C, Maggi E et al. 2000 Role of hormone-controlled Th1- and Th2-type cytokines in successful pregnancy. Neuroimmunology 109, 30-33.
21. Piering WF, Garancis JG, Becker CG et al. 1993 Preeclampsia related to a functioning extrauterine placenta: report of a case and 25-year follow-up. American Journal of Kidney Diseases 21, 310-313.
22. Pijnenborg R, Vercruysse L, Hanssens M 2006 The uterine spiral arteries in human pregnancy: facts and controversies. Placenta February 17; [Epub ahead of print]
23. Rebmann V, Pfeiffer K, Passlerm M et al. 1999 Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 53, 14-22.
24. Redman CW 1991 Current topic: pre-eclampsia and the placenta. Placenta 12, 301-308.
25. Redman CW, Sargent IL 2005 Latest advances in understanding preeclampsia. Science 308, 1592-1594.
26. Redman CW, Sargent IL 2004 Preeclampsia and the systemic inflammatory response. Seminars in Nephrology 24, 565-570.
27. Redman CW, Sargent IL 2003 Pre-eclampsia, the placenta and the maternal systemic inflammatory response - a review. Placenta 24 (Suppl. A), S21-27.
28. Redman CW, Sacks GP, Sargent IL 1999 Preeclampsia: an excessive maternal inflammatory response to pregnancy. American Journal of Obstetrics and Gynecology 180, 499-506.
29. high regulatory T cells in human pregnancy. Journal of Reproductive Immunology 65, 111-120.
30. Sargent IL, Germain SJ, Sacks GP et al. 2003 Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. Journal of Reproductive Immunology 59, 153-160.
31. Sher G, Keskintepe, L, Fisch J et al. 2005 Soluble human leukocyte antigen G expression in phase I culture media at 46 h after fertilization predicts pregnancy and implantation from day 3 embryo transfer. Fertility and Sterility 83, 1410-1413.
32. Slowinski T, Neumayer HH, Stolze T et al. 2002 Endothelin system in normal and hypertensive pregnancy. Clinical Science (London) 103 (Suppl. 48), 446S-449S.
33. Smarason AK, Sargent IL, Starkey PM et al. 1993 The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro. British Journal of Obstetrics and Gynaecology 100, 943-949.
34. Solier C, Aguerre-Girr M, Lenfant F et al. 2002 Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. European Journal of Immunology 32, 3576-3586.
35. Tabiasco J, Rabot M, Aguerre-Girr M et al. 2006 Human decidual NK cells: unique phenotype and functional properties - a review. Placenta 27 (Suppl. A), S34-39.
36. Trowsdale J, Betz AG. (2006) Mother's little helpers: mechanisms of maternal-fetal tolerance. Nature Immunology 7, 241-246.
37. Wegmann TG, Lin H, Guilbert L, Mosmann TR 1993 Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunology Today 14, 353-356.
38. Yie SM, Li LH, Li YM et al. 2004 HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. American Journal of Obstetrics and Gynecology 191, 525-529.
39. Zuckermann FA, Head JR 1986 Expression of MHC antigens on murine trophoblast and their modulation by interferon. Journal of Immunology 137, 846-853.